© The Author 2006. Published by Oxford University Press.
ARTICLE |
Association of Smoking, CpG Island Methylator Phenotype, and V600E BRAF Mutations in Colon Cancer
Affiliations of authors: Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT (WSS); Health Research Center, Department of Internal Medicine, University of Utah, Salt Lake City, UT (HA, CS, JH, RKW, MLS); Division of Research, Kaiser Permanente, Oakland, CA (BJC); Department of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN (KEA)
Correspondence to: Wade S. Samowitz, MD, Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84132 (e-mail: wade.samowitz{at}aruplab.com).
Background: Cigarette smoking has been associated with microsatellite instability in sporadic colon cancer. Most microsatellite-unstable colon cancers have widespread methylation of CpG islands (i.e., the CpG island methylator phenotype [CIMP]), and many of these tumors harbor the V600E BRAF mutation. We investigated whether the association between smoking and all colon cancers could be explained through induction of CIMP and/or BRAF mutations. Methods: We evaluated 1315 case patients with colon cancer and 2392 control subjects in a population-based study. Demographic information, including smoking history, was obtained in an interview. Microsatellite instability was determined primarily by evaluation of the mononucleotide repeat BAT-26. CIMP was determined by sodium bisulfite modification of DNA followed by methylation-specific polymerase chain reaction amplification of CpG islands in hMLH1, p16, and MINTS1, -2, and -31. Tumors were scored as CIMP high (i.e., 
2 CpG islands methylated) or CIMP low (i.e., <2 CpG islands methylated). BRAF V600E mutations were identified by sequencing. Logistic regression was used to quantify relationships among smoking, CIMP, and BRAF. All statistical tests were two-sided. Results: Heavy smoking (i.e., >20 cigarettes per day), compared with nonsmoking, was associated with an increased risk of CIMP-high colon cancer (odds ratio [OR] = 2.06, 95% confidence interval [CI] = 1.43 to 2.97) and also with BRAF V600E mutations (OR = 3.16, 95% CI = 1.80 to 5.54). The association between cigarette smoking and the risk of colon cancer was limited to the minority of tumors that were CIMP high and BRAF wild type or CIMP high and BRAF mutated (for heavy smokers, OR = 1.91, 95% CI = 1.23 to 2.97, and OR = 2.85, 95% CI = 1.53 to 5.29, respectively). All relationships above showed a statistically significant relationship to amount smoked (Ptrend<.001 for all, except that relationship with tumors that were CIMP high and BRAF wild type, for which Ptrend = .008) and were independent of microsatellite instability. Conclusions: Previously identified associations between smoking and colon cancer, whether microsatellite unstable or stable, appear to be explained by the association of smoking with CIMP and BRAF mutations.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. R. English, J. P. Young, J. A. Simpson, M. A. Jenkins, M. C. Southey, M. D. Walsh, D. D. Buchanan, M. A. Barker, A. M. Haydon, S. G. Royce, et al. Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1774 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Young, M. Jenkins, S. Parry, B. Young, D. Nancarrow, D. English, G. Giles, and J. Jass Serrated pathway colorectal cancer in the population: genetic consideration Gut, October 1, 2007; 56(10): 1453 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Curtin, M. L. Slattery, C. M. Ulrich, J. Bigler, T. R. Levin, R. K. Wolff, H. Albertsen, J. D. Potter, and W. S. Samowitz Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet Carcinogenesis, August 1, 2007; 28(8): 1672 - 1679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Samowitz The CpG Island Methylator Phenotype in Colorectal Cancer J. Mol. Diagn., July 1, 2007; 9(3): 281 - 283. [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Samowitz, M. L. Slattery, C. Sweeney, J. Herrick, R. K. Wolff, and H. Albertsen APC Mutations and Other Genetic and Epigenetic Changes in Colon Cancer Mol. Cancer Res., February 1, 2007; 5(2): 165 - 170. [Abstract] [Full Text] [PDF]
|
|